Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC)

Vaccine

Volumn 29, Issue 49, 2011, Pages 9171-9176

  Ahmed, Faruque ^a   Temte, Jonathan L ^b   Campos Outcalt, Doug ^c   Schünemann, Holger J ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Centers for Disease Control and Prevention; Evidence based medicine; Evidence based practice; Immunization; Preventive health services; Vaccination

Indexed keywords

CLINICAL DECISION MAKING; CONCEPTUAL FRAMEWORK; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HUMAN ROTAVIRUS; IMMUNIZATION; INFECTION CONTROL; INFECTION RISK; INFECTIOUS DIARRHEA; INTUSSUSCEPTION; OBSERVATIONAL STUDY; PHARMACOECONOMICS; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROTAVIRUS INFECTION; SYSTEMATIC ERROR; UNITED STATES;

ADVISORY COMMITTEES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DECISION MAKING; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNIZATION; UNITED STATES; VACCINES;

EID: 82555164974     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.005     Document Type: Review

References (35)

1. Smith J.C., Snider D.E., Pickering L.K. Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices. Ann Intern Med 2009, 150(1):45-49.
2. Smith J.C. The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP). Vaccine 2010, 28(Suppl 1):A68-A75.
3. Charter of the Advisory Committee on Immunization Practices (ACIP). CDC. [accessed 12.09.10]. Ref type: Generic. http://www.cdc.gov/vaccines/recs/acip/charter.htm.
4. Bryson M., Duclos P., Jolly A., Cakmak N. A global look at national Immunization Technical Advisory Groups. Vaccine 2010, 28(Suppl 1):A13-A17.
5. Bryson M., Duclos P., Jolly A., Bryson J. A systematic review of national immunization policy making processes. Vaccine 2010, 28(Suppl 1):A6-A12.
6. Erickson L.J., De W.P., Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005, 23(19):2470-2476.
7. Houweling H., Verweij M., Ruitenberg E.J. Criteria for inclusion of vaccinations in public programmes. Vaccine 2010, 28(17):2924-2931.
8. Piso B., Wild C. Decision support in vaccination policies. Vaccine 2009, 27(43):5923-5928.
9. Centers for Disease Control and Prevention. Vaccines & immunizations. Available from: [accessed on 11.18.10]. Ref type: Generic. http://www.cdc.gov/vaccines.
10. U.S. Department of Health and Human Services. Healthy People. Available from: [accessed 11.18.10]. Ref type: Generic. http://www.healthypeople.gov/.
11. Guyatt G.H., Oxman A.D., Vist G.E., Kunz R., Falck-Ytter Y., onso-Coello P., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336(7650):924-926.
12. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005, 54(36):893-897.
13. Samandari T., Bell B.P., Armstrong G.L. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 2004, 22(31-32):4342-4350.
14. American Academy of Pediatrics Steering Committee on Quality Improvement and Management Classifying recommendations for clinical practice guidelines. Pediatrics 2004, 114(3):874-877.
15. Atkins D., Best D., Briss P.A., Eccles M., Falck-Ytter Y., Flottorp S., et al. Grading quality of evidence and strength of recommendations. BMJ 2004, 328(7454):1490.
16. Briss P.A., Zaza S., Pappaioanou M., Fielding J., Wright-De A.L., Truman B.I., et al. Developing an evidence-based Guide to Community Preventive Services-methods. The Task Force on Community Preventive Services. Am J Prev Med 2000, 18(1 Suppl):35-43.
17. Guirguis-Blake J., Calonge N., Miller T., Siu A., Teutsch S., Whitlock E. Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development. Ann Intern Med 2007, 147(2):117-122.
18. Harris R.P., Helfand M., Woolf S.H., Lohr K.N., Mulrow C.D., Teutsch S.M., et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 2001, 20(3 Suppl):21-35.
19. Evidence-based recommendations for immunization-methods of the National Advisory Committee on Immunization. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2009, 35(ACS-1):1-10.
20. GRADE Working Group. Grading of Recommendations Assessment, Development and Evaluation (GRADE). Available from: ; [accessed 01.12.10]. Ref type: Generic. http://www.gradeworkinggroup.org/.
21. Guyatt G.H., Oxman A.D., Kunz R., Vist G.E., Falck-Ytter Y., Schunemann H.J. What is " quality of evidence" and why is it important to clinicians?. BMJ 2008, 336(7651):995-998.
22. Guyatt G.H., Oxman A.D., Kunz R., Vist G.E., Falck-Ytter Y., Schunemann H.J., et al. Going from evidence to recommendations. BMJ 2008, 336(7652):1049-1051.
23. Schunemann H, Brodek J, Oxman A, editors. GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2 [updated March 2009]. The GRADE Working Group; 2009. Available from: [accessed 15.07.11]. Ref type: Generic. http://ims.cochrane.org/gradepro.
24. Methods reference guide for effectiveness and comparative effectiveness reviews. Agency for Healthcare Research and Quality; 2007. Available from: [cited 13.06.08]. http://effectivehealthcare.ahrq.gov/repFiles/2007_10DraftMethodsGuide.pdf.
25. Glanz J.M., McClure D.L., Xu S., Hambidge S.J., Lee M., Kolczak M.S., et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol 2006, 59(8):808-818.
26. Bross I.D. Pertinency of an extraneous variable. J Chronic Dis 1967, 20(7):487-495.
27. Glasziou P., Chalmers I., Rawlins M., McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007, 334(7589):349-351.
28. Cortese M.M., Parashar U.D. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58(RR-2):1-25.
29. Marin M., Broder K.R., Temte J.L., Snider D.E., Seward J.F. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010, 59(RR-3):1-12.
30. Grosse S.D., Teutsch S.M., Haddix A.C. Lessons from cost-effectiveness research for United States public health policy. Annu Rev Public Health 2007, 28:365-391.
31. Centers for Disease Control and Prevention Guidance for presentation of economic studies to the Advisory Committee on Immunization Practices. MMWR 2008, 57(5):125-126.
32. Food and Drug Administration. Clinical Review of New Biologics License Application STN #125122 RotaTeq. 2006. Available from: ; [accessed 26.03.10]. Ref type: Generic. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094063.htm.
33. Block S.L., Vesikari T., Goveia M.G., Rivers S.B., Adeyi B.A., Dallas M.J., et al. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life. Pediatrics 2007, 119(1):11-18.
34. Parashar U.D., Alexander J.P., Glass R.I. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(RR-12):1-13.
35. Vesikari T., Matson D.O., Dennehy P., Van D.P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(1):23-33.